Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- How Drug Advertising Restrictions Could Benefit the Industry
- The drug business spends $5 billion a year on advertising and yet studies continue to emerge suggesting that hundreds of millions of those dollars are wasted. Perhaps it's time to consider whether more restrictions on drug ads might, counterintutively, benefit the industry. ...
- Blog posts 2009-11-05
- Movie Starring Harrison Ford Tells of Novazyme CEO John Crowley's Quest to Save His Children
- The drug industry is about to get a healthy dose of heartwarming goodness with the release of the movie Extraordinary Measures, about Novazyme CEO John Crowley's quest to save his kids from Pompe disease. by Trista Morrison
- Blog posts 2009-11-12
Additional Resources
- The Food and Drug Administration is pushing the use of RFID (radio frequency identification) technology to improve the safety and efficiency of manufacturing and distribution in the drug industry.(RFID News)(Brief Article)
- The Food and Drug Administration is pushing the use of RFID radio frequency identification technology to improve the safety and efficiency of manufacturing and distribution in the drug industry. In early 2004, the FDA issued a report that recomme The Food and Drug Administration...
- Research articles 2005-01-13
- US Drug Industry Wary of Efforts to Weaken Patents.(US drug industry worried its patents could be put in jeopardy by global effort to make pharmaceuticals more widely available in developing countries)
- AN INTERNATIONAL EFFORT to make pharmaceuticals more widely available in developing countries is raising concern in the US drug industry that protection for its valuable patents could be in jeopardy. The World Health Organization WHO WHO is co AN INTERNATIONAL EFFORT to make...
- Research articles 1998-05-18
- Ziegler keeps chain drug industry on cutting edge
- ALEXANDRIA, Va.--There is no argument about whether Ron Ziegler will help lead chain drug retailing into the new millennium. After all, many industry observers contend, he has already started to do so. In taking the National Association of Chain Drug Stores to rarefied heights and making its meetings the...
- Research articles 1998-09-14
- Drug problem; Biodefence.(The drug industry and terrorism)(Acambis)
- A worrying failure to engage the drug industry in the war on terror A worrying failure to engage the drug industry in the war on terror
- Research articles 2004-04-24
- Generic Drug Industry Faces Regulatory and Patent Issues.
- DELAYS TO MARKET ENTRY of generic products are prompting the generic drug industry to reevaluate and challenge regulatory and patent laws. Among the industry's key concerns is inadequate regulation of the 180-day exclusivity period included in the DELAYS TO MARKET ENTRY of generic...
- Research articles 1999-04-12
- Generic drug industry pushes for faster consumer access. (Markets).
- THE GENERIC drug industry is urging lawmakers to retain provisions in final Medicare drug legislation that are intended to speed consumer access to cheaper generic products. The generic drug language was included in separate bills passed by the House and the...
- Research articles 2003-07-21
- US Drug Industry Wary of Efforts to Weaken Patents
- AN INTERNATIONAL EFFORT to make pharmaceuticals more widely available in developing countries is raising concern in the US drug industry that protection for its valuable patents could be in jeopardy. The World Health Organization WHO WHO is co AN INTERNATIONAL EFFORT to make...
- Research articles 1998-05-18
- Drug Industry concerned With USPS irradiation plan. (News).(Brief Article)
- DRUG INDUSTRY officials are voicing concern that a plan by the US Postal Service USPS to irradiate mail to kill potential biological weapons could harm the efficacy and safety of pharmaceuticals. "We cannot underscore enough our concern DRUG INDUSTRY...
- Research articles 2002-01-28
- FDA faults drug industry for approval misses
- The drug industry is at fault for causing the majority of drug "approvable" decisions and failing to win an approval during the first review cycle, FDA Office of New Drugs Director John Jenkins told the Drug Information Association's annual meeting in Chicago on June 20. He told the DIA that...
- Research articles 2002-08-01
- From bench to bedside; The drug industry.(financing drug discovery)
- Could a new business model revive drug discovery? "RAILROADS and telegraphs needed the modern corporation and semiconductors and software needed venture capital," says Gary Pisano. The Harvard Business School professor argues in a new book* that the drug industry is also in desperate need...
- Research articles 2006-11-04
- Sepracor Provides Update On Progress Of R-Albuterol At Mabon Securities Drug Industry Conference
- MARLBOROUGH, Mass.--BUSINESS WIRE--February 21, 1995 -- Sepracor Inc. (NASDAQ: SEPR) recently discussed the progress of its R-albuterol project at Mabon Securities Corp.'s Drug Industry Conference in New York.
- Research articles 1995-02-21
- Drug industry threatens to derail Afghanistan's state building; Counter-narcotics efforts have deepened corruption and hurt the poorest, says new report.
- M2 PRESSWIRE-28 November 2006-WORLD BANK: Drug industry threatens to derail Afghanistan's state building; Counter-narcotics efforts have deepened corruption and hurt the poorest, says new reportC1994-2006 M2 COMMUNICATIONS LTD RDATE:28112006 WASHINGTON - Efforts to combat opium production in Afghanistan have been...
- Research articles 2006-11-28
- NNIT A/S, a provider of IT consulting and services for the drug industry
- NNIT A/S, a provider of IT consulting and services for the drug industry, and LabVantage Solutions established a partnership in Germany, Austria and German-speaking regions of Switzerland and Luxembourg.
- Research articles 2006-11-30
- Drug Makers Gave Lobbyists an Xmas Gift -- Millions More to Lobby Obama Administration
- A New Year will bring a new president, a new FDA chief, many new drug regulations, and, possibly, health insurance reform. Mindful of the ton of major drug brands that will go off-patent in 2009, drug companies have not rested in their lobbying efforts over generics and patent issues. They...
- Blog posts 2008-12-31
- Man Bites Dog: Former Merck CEO Blasts High Drug Prices
- Most pharmaceutical companies insist that high drug prices are a natural consequence of the risky business of drug discovery, and that huge profits on marketed drugs are necessary to cover the costs of the 5,000 to 10,000 experimental drugs that fail for every one that succeeds. In fact, there are...
- Blog posts 2008-05-05
- FDA Loosens Rules for Overseas Drug Trials
- Merrill Goozner, a former Chicago Tribune reporter turned public-health advocate he heads up the Integrity in Science Project at the Center for Science in the Public Interest, notes an interesting and almost wholly overlooked Food and Drug Administration decision that may have the effect of subjecting clinical-trial volunteers in poor...
- Blog posts 2008-05-08
- Safety Officials Get a Seat at the Drug-Regulation Table
- The pharmaceutical industry is finally facing one of its worst-case scenarios: FDA's drug-safety officials will now hold considerably more sway over both experimental and approved drugs. Prodded by Congress in the wake of several major drug-safety and effectiveness concerns --Â starting, perhaps, with Vioxx, and since expanded...
- Blog posts 2008-07-01
- Generic Drugs: Industry Snapshot
- Mike Havrilla submits:Global Generic Drug Industry: Benchmark Comps Global Generic Drug Industry: Top 5 Companies by Market Cap Global Generic Drugs: Top 5 Companies by Stock Performance The accompanying tables provide a snapshot of my 38-company Global Generic Drug Index, which is rapidly consolidating amidst a flurry of recent M&A activity --...
- External links 2008-08-15
- << Previous
- page 1 of 1
- Next >>
